7-Hydroxymitragynine (7-OH): What Parents Should Know

3-minute read • For parents, caregivers, and coaches

Your teen may be told kratom is just a “natural herb.” Inside their body, that kratom can turn into 7-hydroxymitragynine (7-OH) — a compound that locks onto the same brain receptors as prescription opioids. That means opioid-type effects, including dependence and withdrawal, are possible even when the package looks harmless.

Why 7-OH Matters

Potent at opioid receptors. Lab and animal studies show 7-OH has strong μ-opioid activity and can be more potent than morphine in certain models.1,4–5

Formed in the body. Human research confirms measurable 7-OH after kratom use, consistent with metabolic conversion from mitragynine.2

Real-world harms. Poison-center cases, medical reports, and CDC data link kratom use to dependence, withdrawal, and some overdose deaths where kratom was detected.6–9

Not an approved medicine. FDA has not approved kratom or 7-OH for any use, and has raised safety and adulteration concerns.10

Parent Playbook

You don’t have to be a toxicologist to protect your kids. Start with what it looks like, what to watch for, and what to do in an emergency.

What it looks like. 7-OH is not usually sold by name; it’s inside kratom powders, capsules, shots, and gummies labeled as “energy,” “focus,” “mood,” or “relaxation.”

Warning signs. Pinpoint pupils, nausea, constipation, heavy sedation, or withdrawal (anxiety, sweating, tremor, sleeplessness) when stopping heavy use.6–8

If someone is in trouble. For extreme sleepiness, slowed breathing, or unresponsiveness, call 911 right away. For guidance in less urgent situations, call Poison Control: 1-800-222-1222.

How to talk about it. “It’s sold like a supplement, but your body turns it into a chemical that acts on the same brain receptors as opioids. I’m not here to punish you — I just don’t want you blindsided by something packaged like candy.”

Download 7-OH Parent PDF

What 7-OH Products Look Like on the Shelf

These photos show how 7-hydroxymitragynine (7-OH) appears in kratom tablets, capsules, and liquid shots marketed as “natural energy,” “relaxation,” or “focus.” They’re often sold beside candy, vapes, or energy drinks — creating a false sense of safety for young buyers.

Videos: What News Stations Are Warning About 7-Hydroxymitragynine (7-OH)

These verified news reports show how 7-OH products are being sold, why states are banning them, and what doctors and investigators are seeing in emergency rooms. Parents often understand the risks better after hearing it directly from medical experts and reporters covering real cases.

Myths vs. Facts

Myth: “It’s natural, so it can’t be an opioid.”
Fact: 7-OH binds μ-opioid receptors — “natural” origin doesn’t make a drug safe.1,4–5

Myth: “It’s a safe way to manage withdrawal.”
Fact: Case reports show kratom can cause dependence and opioid-like withdrawal; no FDA-approved uses exist.6–8,10

Myth: “If it’s sold in stores, it’s regulated like medicine.”
Fact: These are not approved drugs; oversight is limited and mislabeling/adulteration occur.10

What You Can Do Next

If 7-OH and kratom are new to you, you’re not alone. Many parents, coaches, and community leaders are just now learning how gas-station products can act like opioids in the body. Here are practical next steps:

Check your home and car. Look for kratom powders, capsules, or shots — and any “energy,” “focus,” or “relax” products your child can’t clearly explain.

Have one honest conversation. Ask open-ended questions: “What do you know about kratom?” “Has anyone at school or online mentioned it?” Listen first, then share what you’ve learned here.

Share this page with another adult. Forward this link to one other parent, coach, or school staff member so they know what 7-OH is and what to look for.

Learn about related products. Visit our Information Center to see other “gas-station high” products that target kids and young adults.

References

Every statement on this page is backed by peer-reviewed research and CDC/FDA data. These are some of the key sources:

Show scientific references (for clinicians, researchers, and policymakers)
  1. Kruegel AC, et al. 7-Hydroxymitragynine is an active metabolite of mitragynine. ACS Cent Sci. 2019;5(6):992–1001. link
  2. Huestis MA, et al. Human mitragynine & 7-OH pharmacokinetics after kratom. Molecules. 2024;29(5):984. link
  3. Hill R, et al. Respiratory effects & metabolism to 7-OH. Br J Pharmacol. 2022;179(14):3875–3885. link
  4. Matsumoto K, et al. Antinociceptive effect of 7-OH in mice. Life Sci. 2004;74(17):2143–2155. link
  5. Matsumoto K, et al. μ-receptor involvement in 7-OH effects. Eur J Pharmacol. 2006;549(1–3):63–70. link
  6. Olsen EOM, et al. Kratom detected in overdose deaths — 27 states. MMWR. 2019;68(14):326–327. link
  7. CDC. SUDORS Final Data Dashboard (2020–2023). link
  8. Gummin DD, et al. 2023 NPDS Annual Report. Clin Toxicol (Phila). 2024;62(12):e1–e1261. link
  9. Weiss ST, Douglas HE. Treating kratom withdrawal with buprenorphine/naloxone. J Addict Med. 2021;15(2):167–172. link
  10. U.S. FDA. FDA and Kratom — Public Health Focus (current). link
← Back to Information Center